Cashion Charles

Avg. Two Year Performance

(51%) Avg. Purchase Return
(23%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(7%)4%16%(2%)(51%)
Purchase Success Rate0 of 11 of 11 of 10 of 10 of 1
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

SVP, Finance, CFO and Sec.:

Holdings: 187.16K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Other

Director:

Holdings: 29.52K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--